Safety, Tolerability and Preliminary Efficacy of Multiple Intra-articular Injections of LRX712 in Patients With Knee OA

NCT04097379 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

45

Enrollment

INDUSTRY

Sponsor class

Conditions

Osteoarthritis (OA)

Interventions

DRUG: LRX712
OTHER: Placebo

Sponsor

Novartis Pharmaceuticals